期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 19, 期 1, 页码 -出版社
MDPI
DOI: 10.3390/ijms19010251
关键词
acute myeloid leukemia; integrin; beta3
资金
- Oyvinn Molbach-Petersen's foundation, Helse Vest
- University of Bergen
- Norwegian Cancer Society
Acute myeloid leukemia (AML) is an aggressive bone marrow malignancy where the immature leukemia cells communicate with neighboring cells through constitutive cytokine release and through their cell surface adhesion molecules. The primary AML cells express various integrins. These heterodimeric molecules containing an and a chain are cell surface molecules that bind extracellular matrix molecules, cell surface molecules and soluble mediators. The 3 integrin (ITGB3) chain can form heterodimers only with the two chains IIb and V. These integrins are among the most promiscuous and bind to a large number of ligands, including extracellular matrix molecules, cell surface molecules and soluble mediators. Recent studies suggest that the two 3 integrins are important for leukemogenesis and chemosensitivity in human AML. Firstly, IIb and 3 are both important for adhesion of AML cells to vitronectin and fibronectin. Secondly, 3 is important for the development of murine AML and also for the homing and maintenance of the proliferation for xenografted primary human AML cells, and for maintaining a stem cell transcriptional program. These last effects seem to be mediated through Syk kinase. The 3 expression seems to be regulated by HomeboxA9 (HoxA9) and HoxA10, and the increased 3 expression then activates spleen tyrosine kinase (Syk) and thereby contributes to cytokine hypersensitivity and activation of 2 integrins. Finally, high integrin V/3 expression is associated with an adverse prognosis in AML and decreased sensitivity to the kinase inhibitor sorafenib; this integrin can also be essential for osteopontin-induced sorafenib resistance in AML. In the present article, we review the experimental and clinical evidence for a role of 3 integrins for leukemogenesis and chemosensitivity in AML.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据